Firms

MPM BioImpact
MPM BioImpact is a Boston-based biotechnology investment firm that builds and finances drug development companies across private and public markets. It combines MPM Capital’s biotechnology venture investing with BioImpact’s public-market and impact investing, managing more than USD3 billion across early-stage venture funds, private/public impact funds and a public equities fund. Its investment professionals and entrepreneur partners provide scientific expertise, company formation and drug development leadership. Neuroscience investments include Arialys Therapeutics, AstronauTx and Reunion Neuroscience. The current website is published by MPM BioImpact LLC; MPM Capital and other affiliated legal entities and historical funds retain distinct identities. Aggregate assets under management are not the capital of a single fund.
- Founded
- —
- Type
- Venture capital
Funds0
No funds on record yet.




































